Stock Rating Upgrade
The Value Trend Rating for Adverum Biotechnologies Inc (NASDAQ: ADVM) improved in the last week from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
Adverum Biotechnologies Inc (NASDAQ: ADVM) stock enjoyed a large increase of 5.0% on 9/27/24. The stock closed at $6.94. However, unusually low trading volume at 54% of normal accompanied the advance. The stock has declined -7.5% during the last week and has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
ADVM is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Adverum Biotechnologies has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Adverum Biotechnologies has a neutral Appreciation Score of 60 but a poor Power Rating of 26, producing the Low Neutral Value Trend Rating.
Be the first to comment